Financial Ruin Looms
A stark reality has emerged from a recent multi-centre study conducted across India, revealing that a staggering seven out of ten heart failure patients
are left without a financial safety net. This critical lack of protection means that a vast majority of individuals grappling with this chronic condition are compelled to shoulder an immense financial burden. The research underscores that a significant portion of total healthcare expenditure, often exceeding 90%, comes directly from patients' pockets. This overwhelming out-of-pocket spending is not merely an inconvenience; it's a primary driver of profound economic distress, leading many to consider heart failure not just a threat to life, but a cause of household impoverishment. The study points out that the absence of insurance can escalate spending by a substantial 28 to 38 percent, illustrating the direct correlation between financial protection and the overall cost of care.
Insurance Gaps Exposed
While some heart failure patients in India do possess health insurance, the coverage provided is frequently found to be inadequate for the comprehensive and long-term management required by this condition. Only about 30 percent of patients surveyed had some form of insurance. For those without any coverage, the out-of-pocket expenditure accounts for nearly 98 percent of their treatment costs. Even with private insurance, patients still bear approximately 59 percent of expenses. Government social insurance schemes, while offering some relief, still leave patients paying around 74 percent out of pocket. The challenges extend to the nature of these policies themselves; waiting periods before coverage becomes active are often prolonged, and premiums are substantial due to the high-risk nature of heart failure. Crucially, even robust public health insurance programmes like PMJAY, which offer significant annual coverage for in-patient care, often fail to cover essential outpatient consultations, follow-up appointments, and vital medications that are critical for sustained management.
Impact on Livelihoods
The financial strain resulting from heart failure treatment has devastating consequences for patients and their families, often pushing them towards extreme measures to cover medical bills. The study documented that one out of every three individuals and households reported a noticeable decline in their annual income following a heart failure diagnosis. This economic downturn is frequently accompanied by increased borrowing and asset liquidation. Approximately 18 percent of patients experience difficulty in adhering to their prescribed medications simply because of the prohibitive costs involved, a situation that can severely compromise treatment efficacy and patient outcomes. The average cost of a single hospitalization for heart failure was found to be around Rs 1.19 lakh. To cope, a significant majority, about 68 percent of respondents, relied on their personal savings. Another 54 percent sought financial assistance from family members, and 15 percent resorted to borrowing money from friends or relatives. In dire situations, as exemplified by the case of Rajan, a farmer from near Kochi, families are forced to sell vital livelihood assets like livestock to meet immediate hospital charges, leading to long-term financial instability and diminished quality of life.
Pathways to Relief
Addressing the pervasive financial crisis faced by heart failure patients in India necessitates multifaceted policy interventions and enhancements to existing healthcare support systems. Researchers strongly advocate for a comprehensive review and expansion of health insurance policies to offer more robust coverage for chronic conditions like heart failure. A key recommendation is the extension of public insurance schemes, such as PMJAY, to encompass outpatient care, which often constitutes a significant portion of ongoing treatment costs. Furthermore, incorporating essential guideline-directed heart failure therapies onto the national Essential Medicines List and ensuring free availability of these drugs at primary healthcare centres could dramatically reduce out-of-pocket expenses by an estimated 30-40 percent. Such measures are not only crucial for alleviating financial burdens but are also vital for improving medication adherence and ultimately saving lives by enabling timely and consistent medical intervention for this widespread and debilitating condition.
